Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| JPMorgan Chase | 2.72% | $3.59M | $828.34B | 9.98% | 72 Outperform | |
| Enterprise Products Partners | 2.66% | $3.51M | $79.50B | 9.21% | 73 Outperform | |
| ASML Holding | 2.55% | $3.36M | $540.24B | 90.62% | 81 Outperform | |
| Exxon Mobil | 2.48% | $3.28M | $616.51B | 32.54% | 74 Outperform | |
| Novartis | 2.47% | $3.25M | $316.32B | 54.69% | 80 Outperform | |
| Morgan Stanley | 2.43% | $3.20M | $272.63B | 21.93% | 76 Outperform | |
| Nexstar Media Group | 2.37% | $3.12M | $7.08B | 54.25% | 69 Neutral | |
| Merck & Company | 2.37% | $3.12M | $301.74B | 42.02% | 80 Outperform | |
| KLA | 2.35% | $3.10M | $192.71B | 89.76% | 77 Outperform | |
| Broadcom | 2.30% | $3.03M | $1.58T | 45.38% | 76 Outperform |